The purpose of this study is to measure the immune response (how the body fights infection)
to an experimental preparation of live Respiratory Syncytial Virus (RSV). A better
understanding of this virus may be useful in development of vaccines and treatments.
Participants will include 20 healthy adults age 21-40. Study procedures will include drawing
blood, urine samples, respiratory exams, vital signs and temperature, diary cards, nasal
mucus weight and nasal washes and swabs. All participants will receive vaccine via nose
drops. Patients will participate in the study for about 2 months.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)